DK128353B - Analogifremgangsmåde til fremstilling af terapeutisk aktive bis-chromoner. - Google Patents

Analogifremgangsmåde til fremstilling af terapeutisk aktive bis-chromoner.

Info

Publication number
DK128353B
DK128353B DK500371AA DK500371A DK128353B DK 128353 B DK128353 B DK 128353B DK 500371A A DK500371A A DK 500371AA DK 500371 A DK500371 A DK 500371A DK 128353 B DK128353 B DK 128353B
Authority
DK
Denmark
Prior art keywords
chromones
preparation
therapeutically active
analogous process
active bis
Prior art date
Application number
DK500371AA
Other languages
English (en)
Inventor
R Altounyan
C Fitzmaurice
T Lee
Original Assignee
Fisons Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19691918142 external-priority patent/DE1918142A1/de
Priority claimed from DE19691920365 external-priority patent/DE1920365A1/de
Application filed by Fisons Pharmaceuticals Ltd filed Critical Fisons Pharmaceuticals Ltd
Publication of DK128353B publication Critical patent/DK128353B/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/24—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/673—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/16—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 7
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Apparatuses For Bulk Treatment Of Fruits And Vegetables And Apparatuses For Preparing Feeds (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK500371AA 1965-03-25 1971-10-14 Analogifremgangsmåde til fremstilling af terapeutisk aktive bis-chromoner. DK128353B (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB12626/65A GB1144905A (en) 1965-03-25 1965-03-25 Substituted bis-(2-carboxy-chromonyl-oxy) derivatives and preparation and pharmaceutical compositions thereof
GB5241465 1965-12-09
GB5374465 1965-12-17
GB37765/68A GB1144906A (en) 1965-03-25 1968-08-07 Bis-phenoxy derivatives
DE19691918142 DE1918142A1 (de) 1969-04-10 1969-04-10 Verfahren zur Herstellung von Bischromonverbindungen
DE19691920365 DE1920365A1 (de) 1969-04-22 1969-04-22 Verfahren zur Herstellung von Bis-Chromonen

Publications (1)

Publication Number Publication Date
DK128353B true DK128353B (da) 1974-04-16

Family

ID=27544127

Family Applications (4)

Application Number Title Priority Date Filing Date
DK156266AA DK134646B (da) 1965-03-25 1966-03-25 Analogifremgangsmåde til fremstilling af bis-chromoner.
DK500271AA DK128318B (da) 1965-03-25 1971-10-14 Analogifremgangsmåde til fremstilling af terapeutisk aktive bischromoner.
DK500171AA DK128245B (da) 1965-03-25 1971-10-14 Analogifremgangsmåde til fremstilling af salte af bis-chromon-2-carboxylsyrer.
DK500371AA DK128353B (da) 1965-03-25 1971-10-14 Analogifremgangsmåde til fremstilling af terapeutisk aktive bis-chromoner.

Family Applications Before (3)

Application Number Title Priority Date Filing Date
DK156266AA DK134646B (da) 1965-03-25 1966-03-25 Analogifremgangsmåde til fremstilling af bis-chromoner.
DK500271AA DK128318B (da) 1965-03-25 1971-10-14 Analogifremgangsmåde til fremstilling af terapeutisk aktive bischromoner.
DK500171AA DK128245B (da) 1965-03-25 1971-10-14 Analogifremgangsmåde til fremstilling af salte af bis-chromon-2-carboxylsyrer.

Country Status (16)

Country Link
US (2) US3419578A (da)
JP (5) JPS5341662B1 (da)
BE (1) BE678175A (da)
CH (1) CH486445A (da)
DE (1) DE1543579C3 (da)
DK (4) DK134646B (da)
FR (1) FR5452M (da)
GB (2) GB1144905A (da)
IL (1) IL25317A (da)
IT (1) IT1047628B (da)
MY (1) MY7000043A (da)
NL (1) NL147732B (da)
NO (3) NO124875B (da)
OA (1) OA03872A (da)
SE (3) SE355184B (da)
YU (1) YU32999B (da)

Families Citing this family (88)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862175A (en) * 1965-03-25 1975-01-21 Fison House Bis-chromone compounds
GB1144905A (en) * 1965-03-25 1969-03-12 Fisons Pharmaceuticals Ltd Substituted bis-(2-carboxy-chromonyl-oxy) derivatives and preparation and pharmaceutical compositions thereof
GB1147976A (en) * 1965-12-21 1969-04-10 Fisons Pharmaceuticals Ltd Chromone derivatives
GB1190193A (en) * 1966-07-05 1970-04-29 Fisons Pharmaceuticals Ltd Bis-(2-Carboxy-Chromonyl-Oxy) Derivatives, their preparation, and Pharmaceutical Compositions thereof
US3957965A (en) * 1967-08-08 1976-05-18 Fisons Limited Sodium chromoglycate inhalation medicament
US3860618A (en) * 1967-08-08 1975-01-14 Philip Saxton Hartley Chromone
GB1292601A (en) * 1968-10-30 1972-10-11 Fisons Pharmaceuticals Ltd Bis-(2-carboxy-chromone) compounds, their preparation and pharmaceutical compositions containing them
GB1340512A (en) * 1970-01-21 1973-12-12 Fisons Ltd Production of esters of chromone-2-carboxylic acids
GB1326745A (en) * 1970-04-25 1973-08-15 Fisons Ltd Chromone-2-carboxylic acid derivatives
US3979407A (en) * 1970-07-31 1976-09-07 Allen & Hanburys Limited Chromone derivatives
US4029802A (en) * 1970-08-27 1977-06-14 Fisons Limited The treatment of asthma, hay fever or urticaria
US3968235A (en) 1970-12-14 1976-07-06 Sandoz Ltd. Composition and method for combating insects with alkylenedioxyphenyl derivatives
US3933804A (en) 1970-12-14 1976-01-20 Sandoz Ltd., (Sandoz Ag) Insecticidal 1,3-benzodioxol derivatives
US4105781A (en) * 1970-12-30 1978-08-08 Fujisawa Pharmaceutical Co., Ltd. Chromone compounds and preparation thereof
US3965122A (en) * 1970-12-30 1976-06-22 Fujisawa Pharmaceutical Co., Ltd. Chromone compounds and preparation thereof
US3975536A (en) 1971-05-12 1976-08-17 Fisons Limited Composition
US4053628A (en) * 1971-05-12 1977-10-11 Fisons Limited Composition
GB1399834A (en) * 1971-05-12 1975-07-02 Fisons Ltd Pharmaceutical compositions
US4006245A (en) * 1971-07-29 1977-02-01 Fisons Limited Chemical compounds
GB1384530A (en) * 1971-07-29 1975-02-19 Fisons Ltd Chromone derivatives
GB1410588A (en) * 1971-08-10 1975-10-22 Fisons Ltd Composition
SU469247A3 (ru) * 1972-01-14 1975-04-30 Майлз Лабораториз Инк (Фирма) Способ получени производных хромона
GB1428186A (en) * 1972-06-21 1976-03-17 Fujisawa Pharmaceutical Co Chromone derivatives
FR2196795A1 (en) * 1972-08-25 1974-03-22 Aries Robert Amine salts of bis(carboxychromones) - useful for treatment of dyspnoea and bronchoconstriction
GB1399647A (en) * 1972-12-15 1975-07-02 Fisons Ltd Phenoxyalkoxy-chromone derivatives processes for their preparation and compositions containing them
FR2210398A1 (en) * 1972-12-20 1974-07-12 Aries Robert Bis-(carboxy-chromone) amino ethoxy-ethyl carboxylate salts - useful as a sedative and prophylactic
US3948954A (en) * 1973-01-19 1976-04-06 Fisons Limited Bis-chromone-tetrazole/hydroxamic/carboxylic acids
FR2217004A1 (en) * 1973-02-15 1974-09-06 Aries Robert Sedatives and bronchodilatories - i.e. salts of 1,3-bis(2-carboxychromon-5-yloxy)propanes with 3-hydroxy-2-hydroxymethyl pyridines
FR2230358A2 (en) * 1973-05-25 1974-12-20 Fisons Ltd Cromoglycate contg. solns. - contg. a second therapeutically active cpd. e.g. an antihistamine
US4046910A (en) * 1974-01-28 1977-09-06 The Upjohn Company Dosage schedule
DE2634908A1 (de) * 1974-11-09 1977-04-14 Fisons Ltd Mittel zur behandlung chronischer haut- oder augenerkrankungen
IE41922B1 (en) * 1974-11-09 1980-04-23 Fisons Ltd Pharmaceutical compositions containing bis-chromones
US4161516A (en) * 1975-07-25 1979-07-17 Fisons Limited Composition for treating airway disease
US4145438A (en) * 1975-09-10 1979-03-20 Fisons Limited Method for treatment of eczema or psoriasis
US4067992A (en) * 1975-09-10 1978-01-10 Fisons Limited Method of treating a psychiatric condition
GB1509979A (en) * 1975-11-28 1978-05-10 Fisons Ltd Pharmaceutical compositions containing aspirin or indomethacin
US4097596A (en) * 1976-11-02 1978-06-27 American Home Products Corporation Inhalation therapy for relieving bronchial spasm using quaternary salts of promethazine
GB1557082A (en) * 1977-01-25 1979-12-05 Fisons Ltd Pharmaceutical mixture containing an antiinflammatory
NZ187192A (en) * 1977-05-06 1982-02-23 Fisons Ltd Prophylactic or curative treatment of allergic conditions in domestic animals using compounds with sodium cromoglycate-like activity
US4192860A (en) * 1977-05-06 1980-03-11 Fisons Limited Methods for treating disease conditions
AU522792B2 (en) * 1977-07-19 1982-06-24 Fisons Plc Pressure pack formulation
FI802783A (fi) * 1979-09-05 1981-03-06 Glaxo Group Ltd Fenolderivat
GB2077100B (en) * 1980-04-30 1985-04-24 Fisons Ltd Pharmaceutical compositions containing cromoglycates
EP0061800B1 (en) * 1981-03-24 1985-08-28 FISONS plc Anti srs-a carboxylic acid derivatives, processes for their production and pharmaceutical formulations containing them
JPS5828509U (ja) * 1981-08-20 1983-02-24 関東電気工事株式会社 分岐箇所用低圧ロ−ラ
US4447449A (en) * 1981-11-16 1984-05-08 The Upjohn Company Methods of treating ischemic states
US4584315A (en) * 1981-11-16 1986-04-22 The Upjohn Company Method of treating ischemic states
US5135940A (en) * 1982-09-23 1992-08-04 Merck Frosst Canada, Inc. Leukotriene antagonists
US4782176A (en) * 1983-01-24 1988-11-01 Hoffmann-La Roche Inc. Phenoxycarboxylic acids
US4581225A (en) * 1984-04-25 1986-04-08 Eli Lilly And Company Sustained release intranasal formulation and method of use thereof
DE3786030T2 (de) 1986-03-27 1993-12-02 Merck Frosst Canada Inc Tetrahydrocarbazole Ester.
US4758678A (en) * 1986-07-18 1988-07-19 Pennwalt Corporation Preparation of 7-(2,3-epoxypropoxy)flavone
US5788983A (en) * 1989-04-03 1998-08-04 Rutgers, The State University Of New Jersey Transdermal controlled delivery of pharmaceuticals at variable dosage rates and processes
CA2053216C (en) 1990-10-12 2003-04-08 Michel L. Belley Saturated hydroxyalkylquinoline acids as leukotriene antagonists
US20010003739A1 (en) * 1993-06-24 2001-06-14 Astrazeneca Ab Systemic administration of a therapeutic preparation
US5830853A (en) 1994-06-23 1998-11-03 Astra Aktiebolag Systemic administration of a therapeutic preparation
US6632456B1 (en) 1993-06-24 2003-10-14 Astrazeneca Ab Compositions for inhalation
US6794357B1 (en) 1993-06-24 2004-09-21 Astrazeneca Ab Compositions for inhalation
GB9317752D0 (en) * 1993-08-26 1993-10-13 Fisons Plc New pharmaceutical use
US5508451A (en) * 1994-07-07 1996-04-16 Hoechst Celanese Corporation Process for the preparation of dialkali metal cromoglycates
SE9404468D0 (sv) * 1994-12-22 1994-12-22 Astra Ab Powder formulations
EE9700136A (et) * 1994-12-22 1997-12-15 Astra Aktiebolag Paratüroidhormooni PTH sisaldav ravimpreparaat inhaleerimiseks
EP0806940B1 (en) 1994-12-22 2003-04-09 AstraZeneca AB Aerosol drug formulations
US6524557B1 (en) * 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
CA2174583A1 (en) * 1995-05-05 1996-11-06 Alexander Chucholowski Sulfuric acid esters of sugar alcohols
US6150400A (en) * 1997-06-30 2000-11-21 Presutti Laboratories Method for treating vulvar vestibulitis
US6596284B1 (en) 2002-04-30 2003-07-22 Thomas E. Fleming Treating eczema with a combination of isotonic saline ocean® and nasal mast cell stabilizers
US20050026880A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a cromone for treatment of asthma or chronic obstructive pulmonary disease
WO2009131695A1 (en) 2008-04-25 2009-10-29 Nektar Therapeutics Oligomer-bis-chromonyl compound conjugates
JP5731406B2 (ja) * 2009-01-29 2015-06-10 ザ ジェネラル ホスピタル コーポレイション クロモリン誘導体、クロモリン誘導体を用いた治療方法及び造影方法
US9925282B2 (en) 2009-01-29 2018-03-27 The General Hospital Corporation Cromolyn derivatives and related methods of imaging and treatment
TR201000733A2 (tr) 2010-02-02 2011-08-22 Bi̇lgi̇ç Mahmut Flutikazon, tiotropyum ve sodyum kromoglikat içeren farmasötik bileşimler.
US20140249180A1 (en) * 2011-10-03 2014-09-04 National Center For Geriatrics And Gerontology Tau aggregation inhibitor
ES2749096T3 (es) 2012-10-25 2020-03-19 Massachusetts Gen Hospital Terapias de combinación para el tratamiento de la enfermedad de Alzheimery transtornos relacionados
US10058530B2 (en) 2012-10-25 2018-08-28 The General Hospital Corporation Combination therapies for the treatment of Alzheimer's disease and related disorders
EP2962687B1 (en) 2013-04-02 2019-06-05 The Doshisha Tau aggregation inhibitor
US10525005B2 (en) 2013-05-23 2020-01-07 The General Hospital Corporation Cromolyn compositions and methods thereof
WO2015061397A1 (en) 2013-10-22 2015-04-30 The General Hostpital Corporation Cromolyn derivatives and related methods of imaging and treatment
AU2015213678C1 (en) 2014-02-10 2019-03-21 Respivant Sciences Gmbh Mast cell stabilizers treatment for systemic disorders
CN106535889A (zh) 2014-02-10 2017-03-22 帕塔拉制药有限责任公司 用于治疗肺疾病的肥大细胞稳定剂
WO2017027402A1 (en) 2015-08-07 2017-02-16 Patara Pharma, LLC Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders
EP3331522A1 (en) 2015-08-07 2018-06-13 Patara Pharma LLC Methods for the treatment of mast cell related disorders with mast cell stabilizers
CA3035528A1 (en) 2016-08-31 2018-03-08 Respivant Sciences Gmbh Cromolyn compositions for treatment of chronic cough due to idiopathic pulmonary fibrosis
WO2018045217A1 (en) 2016-08-31 2018-03-08 The General Hospital Corporation Macrophages/microglia in neuro-inflammation associated with neurodegenerative diseases
AU2017339366A1 (en) 2016-10-07 2019-04-11 Respivant Sciences Gmbh Cromolyn compositions for treatment of pulmonary fibrosis
KR20210070232A (ko) 2017-07-20 2021-06-14 아즈테라피즈 인코포레이티드 크로몰린 나트륨 및 이부프로펜의 분말화된 제형
EP3817739A4 (en) 2018-07-02 2022-04-13 The General Hospital Corporation SODIUM CROMOGLYCATE AND ?-LACTOSE POWDER FORMULATIONS
WO2021094296A1 (en) 2019-11-12 2021-05-20 INSERM (Institut National de la Santé et de la Recherche Médicale) Use of mast cell stabilizer for the treatment of heart failure with preserved ejection fraction

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2769015A (en) * 1954-10-06 1956-10-30 Lab Laroche Navarron Process of preparing 3-methyl-chromone
US3162673A (en) * 1960-12-28 1964-12-22 Union Carbide Corp Bis (aminoaliphatic) carbonates and process for preparation
GB1144905A (en) * 1965-03-25 1969-03-12 Fisons Pharmaceuticals Ltd Substituted bis-(2-carboxy-chromonyl-oxy) derivatives and preparation and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
NO124832B (da) 1972-06-12
FR5452M (da) 1967-10-16
DK134646B (da) 1976-12-13
DK134646C (da) 1977-05-16
DK128318B (da) 1974-04-08
OA03872A (fr) 1971-12-24
SE371185B (da) 1974-11-11
DE1543579A1 (de) 1969-11-06
CH486445A (fr) 1970-02-28
NL6603997A (da) 1966-09-26
NO137497B (no) 1977-11-28
YU177066A (en) 1975-08-31
NO137497C (no) 1978-03-08
DE1543579B2 (de) 1980-01-03
JPS4843506B1 (da) 1973-12-19
DK128245B (da) 1974-03-25
IT1047628B (it) 1980-10-20
US3671625A (en) 1972-06-20
YU32999B (en) 1976-03-31
SE355184B (da) 1973-04-09
SE372941B (da) 1975-01-20
NL147732B (nl) 1975-11-17
JPS5343493B1 (da) 1978-11-20
GB1144906A (en) 1969-03-12
GB1144905A (en) 1969-03-12
JPS5341662B1 (da) 1978-11-06
MY7000043A (en) 1970-12-31
BE678175A (da) 1966-09-21
JPS5341663B1 (da) 1978-11-06
NO124875B (da) 1972-06-19
JPS5343492B1 (da) 1978-11-20
IL25317A (en) 1970-08-19
DE1543579C3 (de) 1980-08-28
US3419578A (en) 1968-12-31

Similar Documents

Publication Publication Date Title
DK128353B (da) Analogifremgangsmåde til fremstilling af terapeutisk aktive bis-chromoner.
DK133618B (da) Analogifremgangsmåde til fremstilling af 1-hydroxyaryl-2-aminoalkanoler.
DK118769B (da) Fremgangsmåde til fremstilling af O-methyl-S-methyl-phosphoroamidothioat.
DK115474B (da) Analogifremgangsmåde til fremstilling af N-p-chlorbenzoyl-5-fluorcytosin.
FI49497C (fi) Menetelmä terapeuttisesti vaikuttavien 1-fenoksi-2-3-alkyyliaminopropa anien valmistamiseksi.
DK118505B (da) Fremgangsmåde til fremstilling af isoindolin-2-sulfonylurinstoffer.
DK118239B (da) Fremgangsmåde til fremstilling af substituerede 4-hydroxykinoliner.
DK113645B (da) Fremgangsmåde til fremstilling af terapeutisk virksomme indolyl-3-alkan-carboxylsyrer.
DK115400B (da) Fremgangsmåde til fremstilling af terapeutisk virksomme 3-keto-19-alkyl-androstaner.
DK121708B (da) Analogifremgangsmåde til fremstilling af terapeutisk virksomme 22-aza-cholestanderivater.
DK117635B (da) Analogifremgangsmåde til fremstilling af terapeutisk virksomme 3-(piperazinoalkyl)-pyrazoler.
DK135234B (da) Analogifremgangsmåde til fremstilling af piperazin-phenylethanolforbindelser.
DK122760B (da) Analogifremgangsmåde til fremstilling af terapeutisk virksomme 4-alkoxy-3,5-dimethoxybenzamider.
DK118825B (da) Fremgangsmåde til fremstilling af adrenocorticotropt virksomme tricosa- eller tetracosapeptider.
DK118717B (da) Fremgangsmåde til fremstilling af antidiabetisk virksomme benzensulfonamidopyrimidiner.
DK117488C (da) Fremgangsmåde til fremstilling af terapeutisk aktive 2α-3α-epithio-5α-androstaner.
DK118670B (da) Fremgangsmåde til fremstilling af cyanphenoler.
DK118458B (da) Fremgangsmåde til fremstilling af 5-halogen-2-amino-benzophenoniminer.
DK116658B (da) Fremgangsmåde til fremstilling af terapeutisk aktive 7α-methyl-Δ<5>-østrener.
DK122223B (da) Analogifremgangsmåde til fremstilling af terapeutisk aktive biphenylforbindelser.
DK122527B (da) Fremgangsmåde til fremstilling af 3-nitro-2-oxo-tetrahydro-imidazoler.
DK119830B (da) Analogifremgangsmåde til fremstilling af arylsulfonylsemicarbazider.
DK113642B (da) Fremgangsmåde til fremstilling af terapeutisk virksomt estradiol-17β-p-tert.butylbenzoat.
DK112585B (da) Fremgangsmåde til fremstilling af diuretisk virksomme 4-chlor-3-sulfonamido-1-benzensulfonamider.
DK114833B (da) Fremgangsmåde til fremstilling af 1-aroyl-3-indolylestere.